Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
Case Study
Unbundled Early Intervention Program Leads to Greater Transparency
Workers' Comp
Article
Empowering Excellence: How Our Dedicated Team Elevates Care for Injured Employees
Our employees’ unwavering dedication to continuous improvement and quality assurance lies at the heart of our customer-centric approach, utilizing
Workers' Comp
Article
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
Will GLP-1 weight loss drugs become more prevalent in workers’ compensation? Glucagon-like peptide 1 (GLP-1)
Workers' Comp
Article
The Regulatory Rollercoaster: A High-Stakes Game of Collaboration and Adaptability
As the workers' compensation and auto industry braces itself for the regulatory changes sweeping across Michigan, Florid
Workers' Comp
Article
6 Considerations for Medical Transportation Arrangements
Beyond convenience, reliable transportation prevents missed appointments that can delay recovery and worsen health outcomes.
Mitchell
Article
Current Used Vehicle Market Conditions: Q2 2024
May/June 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.